Himachal drug firms that - mostly contract manufacturers - are now trying to register as many products as possible before the month ends. This would enable them to manufacture these registered products under new brands even after March 31.
In addition to existing units, some new manufacturing facilities are also desperate to get the drug regulator's approval to start production before the deadline. "There are over 30 companies that are trying to get their new manufacturing facilities registered before the month end. Other applications are from existing manufacturers who are trying to augment their product portfolio," a senior state drug regulatory official said.
According to him, each new company can apply for 10 product approvals without any additional fee. For each extra product, the companies would have to pay Rs 300. With over 480 pharmaceutical units up and running in Himachal alone, the number of last-minute product approvals could amount to a few thousand, industry sources say. The country's biggest drug manufacturing hub is in Baddi, Himachal Pradesh.
Pharmaceutical majors, including Ranbaxy, Dr Reddys and GSK, have manufacturing presence in the state.
Finance ministry: Return of the Gladstonians
Ranbaxy launches GSK's blockbuster drug in US
Fin ministry seeks Idiot's tip for Budget blues
Dr Reddy's posts Rs 522-crore net loss
Dr Reddy's diabetic drug shows promising results